Clinical Trial Update: Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of an intramuscular depot formulation of aripiprazole in adults with schizophrenia. The trial has completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ABILIFY MAINTENA (ARIPIPRAZOLE)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Mental Disorder | Phase 1 | Status: COMPLETED | Results posted: 2015-06-02